Karin Knobe (Former)
1 – 26 of 26
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Evaluation of prophylactic therapy in haemophilia with global coagulation tests
(
- Contribution to journal › Letter
- 2017
-
Mark
Comparative burden of arthropathy in mild haemophilia : a register-based study in Sweden
(
- Contribution to journal › Article
- 2012
-
Mark
Lupus anticoagulants in two children-bleeding due to nonphospholipid-dependent antiprothrombin antibodies.
(
- Contribution to journal › Article
-
Mark
Investigation of disease-associated factors in haemophilia A patients without detectable mutations.
(
- Contribution to journal › Article
-
Mark
New treatments in hemophilia: insights for the clinician.
(
- Contribution to journal › Article
-
Mark
Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX.
(
- Contribution to journal › Article
-
Mark
How to manage invasive procedures in children with haemophilia.
(
- Contribution to journal › Article
- 2011
-
Mark
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
(
- Contribution to journal › Article
-
Mark
Joint protection in haemophilia
(
- Contribution to journal › Article
-
Mark
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
(
- Contribution to journal › Article
-
Mark
Ovanliga ärftliga former av blödarsjuka. Blödningssymtom, familjehistoria och laboratorieanalyser ger diagnosen.
(
- Contribution to journal › Article
- 2010
-
Mark
Hemophilia A patients without detectable mutations - investigation of disease-associated factors
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Female haemophilia A caused by skewed X inactivation
(
- Contribution to journal › Letter
-
Mark
Why does the mutation G17736A/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?
(
- Contribution to journal › Article
- 2006
-
Mark
Functional Analysis of the Factor IX Epidermal Growth Factor-Like Domain Mutation Ile66Thr Associated with Mild Hemophilia B.
(
- Contribution to journal › Article
- 2003
-
Mark
Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B.
(
- Contribution to journal › Article
-
Mark
HEMOPHILIA A AND B WITH SPECIAL REFERENCE TO INHIBITOR DEVELOPMENT AND EXPERIMENTAL STUDIES OF FACTORS VIII AND IX
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Breastfeeding does not influence the development of inhibitors in haemophilia.
(
- Contribution to journal › Article
-
Mark
The N-terminal EGF domain of coagulation factor IX: Probing its functions in the activation of factor IX and factor X with a monoclonal antibody.
(
- Contribution to journal › Article
-
Mark
Inhibitors in the Swedish population with severe haemophilia A and B : A 20-year survey
(
- Contribution to journal › Article
- 2001
-
Mark
An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX
(
- Contribution to journal › Article
- 2000
-
Mark
Factor VIII inhibitors in two families with mild haemophilia A: structural analysis of the mutations
(
- Contribution to journal › Article
- 1999
-
Mark
Haemophilia B carrier detection by factor IX:C analysis; no impact of the type of mutation or severity of disorder
(
- Contribution to journal › Article
-
Mark
Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling
(
- Contribution to journal › Article
- 1992
-
Mark
Preprogastrin-releasing peptide messenger ribonucleic acid: neuroanatomical localization in rat brain by in situ hybridization with synthetic oligodeoxynucleotide probes
(
- Contribution to journal › Article
-
Mark
Distribution of preproatrial natriuretic peptide mRNA in rat brain detected by in situ hybridization of DNA oligonucleotides: enrichment in hypothalamic and limbic regions
(
- Contribution to journal › Article